0001806165-20-000001.txt : 20200316 0001806165-20-000001.hdr.sgml : 20200316 20200316162454 ACCESSION NUMBER: 0001806165-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 EFFECTIVENESS DATE: 20200316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phase 3 Biotech Fund, LP CENTRAL INDEX KEY: 0001806165 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362948 FILM NUMBER: 20717468 BUSINESS ADDRESS: STREET 1: 51 FALCON HILLS DRIVE CITY: HIGHLANDS RANCH STATE: CO ZIP: 80126 BUSINESS PHONE: 650-838-4434 MAIL ADDRESS: STREET 1: 51 FALCON HILLS DRIVE CITY: HIGHLANDS RANCH STATE: CO ZIP: 80126 D 1 primary_doc.xml X0708 D LIVE 0001806165 Phase 3 Biotech Fund, LP 51 FALCON HILLS DRIVE HIGHLANDS RANCH CO COLORADO 80126 650-838-4434 DELAWARE None None Limited Partnership true 2019 a Delaware limited liability company Phase 3 Biotech Fund GP, LLC 51 Falcon Hills Drive Highlands Ranch CO COLORADO 80126 Executive Officer Gordon Andringa 51 Falcon Hills Drive Highlands Ranch CO COLORADO 80126 Executive Officer Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 false 2020-03-02 true true false 0 Indefinite 410750 Indefinite false 4 0 0 0 false Phase 3 Biotech Fund, LP /s/Gordon Andringa Gordon Andringa Manager of the General Partner 2020-03-13